Robert Ferguson

492 total citations
26 papers, 279 citations indexed

About

Robert Ferguson is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Robert Ferguson has authored 26 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Robert Ferguson's work include Cancer Immunotherapy and Biomarkers (12 papers), Immunotherapy and Immune Responses (7 papers) and vaccines and immunoinformatics approaches (5 papers). Robert Ferguson is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Immunotherapy and Immune Responses (7 papers) and vaccines and immunoinformatics approaches (5 papers). Robert Ferguson collaborates with scholars based in United States, United Kingdom and Sweden. Robert Ferguson's co-authors include Tomas Kirchhoff, Iman Osman, Danny Simpson, B. Agate, Lynn Paterson, W. Sibbett, Peter E. Bryant, Frank J. Gunn‐Moore, C. T. A. Brown and A. E. Carruthers and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Robert Ferguson

26 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Ferguson United States 8 126 91 53 45 44 26 279
Maria Velez Netherlands 7 262 2.1× 107 1.2× 48 0.9× 42 0.9× 129 2.9× 11 400
Kaitlin Moore United States 6 128 1.0× 92 1.0× 34 0.6× 83 1.8× 60 1.4× 7 282
David Ruff United States 9 217 1.7× 36 0.4× 29 0.5× 57 1.3× 48 1.1× 18 342
Katherine P. Mueller United States 7 161 1.3× 112 1.2× 53 1.0× 80 1.8× 11 0.3× 12 277
Hanna Björkelund Sweden 12 259 2.1× 170 1.9× 83 1.6× 28 0.6× 19 0.4× 21 464
J. Lee United States 5 161 1.3× 75 0.8× 69 1.3× 17 0.4× 46 1.0× 7 285
Jackson R. Richards United States 8 85 0.7× 28 0.3× 33 0.6× 11 0.2× 34 0.8× 10 193
Marjorie L. Wier United States 11 235 1.9× 91 1.0× 63 1.2× 10 0.2× 50 1.1× 13 384
Andrew Emley United States 9 165 1.3× 193 2.1× 70 1.3× 10 0.2× 37 0.8× 10 306
Emmanuel de Billy Italy 11 247 2.0× 63 0.7× 82 1.5× 14 0.3× 31 0.7× 15 390

Countries citing papers authored by Robert Ferguson

Since Specialization
Citations

This map shows the geographic impact of Robert Ferguson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Ferguson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Ferguson more than expected).

Fields of papers citing papers by Robert Ferguson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Ferguson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Ferguson. The network helps show where Robert Ferguson may publish in the future.

Co-authorship network of co-authors of Robert Ferguson

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Ferguson. A scholar is included among the top collaborators of Robert Ferguson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Ferguson. Robert Ferguson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferguson, Robert, Sonia Dolfi, Daniel J. Tenney, et al.. (2024). Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy–Induced Immune-Related Adverse Events in Melanoma. Clinical Cancer Research. 30(19). 4412–4423. 2 indexed citations
2.
Ferguson, Robert, Danny Simpson, Gabriele Madonna, et al.. (2023). Germline immunomodulatory expression quantitative trait loci (ieQTLs) associated with immune-related toxicity from checkpoint inhibition. European Journal of Cancer. 189. 112923–112923. 6 indexed citations
3.
Moran, Una, Matija Snuderl, Jeffrey S. Weber, et al.. (2023). A genome-wide association study of germline variation and melanoma prognosis. Frontiers in Oncology. 12. 1050741–1050741. 3 indexed citations
4.
Illa-Bochaca, Irineu, Faisal Fa’ak, Robert Ferguson, et al.. (2023). Kinase Insert Domain Receptor Q472H Pathogenic Germline Variant Impacts Melanoma Tumor Growth and Patient Treatment Outcomes. Cancers. 16(1). 18–18. 1 indexed citations
5.
Fa’ak, Faisal, Richard L. Shapiro, Russell S. Berman, et al.. (2023). Distinct genetic and phenotypic characteristics of not otherwise specified (NOS) melanoma.. Journal of Clinical Oncology. 41(16_suppl). e21571–e21571. 1 indexed citations
6.
Ferguson, Robert, Karen Aughton, A.G. Evans, et al.. (2023). Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle Regulation. Current Issues in Molecular Biology. 45(3). 2505–2520. 3 indexed citations
7.
Ferguson, Robert, et al.. (2022). Ultra Low-Coverage Whole-Genome Sequencing as an Alternative to Genotyping Arrays in Genome-Wide Association Studies. Frontiers in Genetics. 12. 790445–790445. 15 indexed citations
8.
Simpson, Danny, et al.. (2021). Tumor immunogenomic signatures improve a prognostic model of melanoma survival. Journal of Translational Medicine. 19(1). 78–78. 4 indexed citations
9.
Kirchhoff, Tomas & Robert Ferguson. (2019). Germline Genetics in Immuno-oncology: From Genome-Wide to Targeted Biomarker Strategies. Methods in molecular biology. 2055. 93–117. 6 indexed citations
10.
Ferguson, Robert, Alexi Archambault, Danny Simpson, et al.. (2019). Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM). Scientific Reports. 9(1). 10173–10173. 5 indexed citations
11.
Ferguson, Robert, Danny Simpson, Una Moran, et al.. (2019). Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition. Cancer Immunology Immunotherapy. 68(6). 897–905. 36 indexed citations
12.
Ferguson, Robert, et al.. (2019). Germline genetic host factors as predictive biomarkers in immuno-oncology. Immuno-Oncology Technology. 2. 14–21. 4 indexed citations
13.
Singh, Navjot, Richard Johnson, Robert Ferguson, et al.. (2017). Identification of regulatory targets for the bacterial Nus factor complex. Nature Communications. 8(1). 2027–2027. 21 indexed citations
14.
Kirchhoff, Tomas, Robert Ferguson, Danny Simpson, et al.. (2017). Germline determinants of immune related adverse events (irAEs) in melanoma immunotherapy response. Annals of Oncology. 28. v407–v408. 4 indexed citations
15.
Simpson, Danny, Robert Ferguson, Una Moran, et al.. (2017). Mutation burden as a potential prognostic marker of melanoma progression and survival.. Journal of Clinical Oncology. 35(15_suppl). 9567–9567. 13 indexed citations
16.
Ferguson, Robert, Matjaž Vogelsang, Karan Rai, et al.. (2016). Genetic markers of pigmentation are novel risk loci for uveal melanoma. Scientific Reports. 6(1). 31191–31191. 30 indexed citations
17.
Paterson, Lynn, B. Agate, Kishan Dholakia, et al.. (2005). Violet diode-assisted photoporation and transfection of cells. 18(8). 30–35. 2 indexed citations
18.
Paterson, Lynn, B. Agate, M. Comrie, et al.. (2005). Photoporation and cell transfection using a violet diode laser. Optics Express. 13(2). 595–595. 57 indexed citations
19.
Paterson, Lynn, B. Agate, M. Comrie, et al.. (2005). Photoporation and cell transfection using a violet diode laser. 3. 1654–1656. 3 indexed citations
20.
Ferguson, Robert, et al.. (1973). Managing Police Organizations. Medical Entomology and Zoology. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Velez Breakdown of academic impact, for papers by Kaitlin Moore Breakdown of academic impact, for papers by David Ruff Breakdown of academic impact, for papers by Katherine P. Mueller Breakdown of academic impact, for papers by Hanna Björkelund Breakdown of academic impact, for papers by J. Lee Breakdown of academic impact, for papers by Jackson R. Richards Breakdown of academic impact, for papers by Marjorie L. Wier Breakdown of academic impact, for papers by Andrew Emley Breakdown of academic impact, for papers by Emmanuel de Billy
Rankless by CCL
2026